Prudential Financial Inc Prelude Therapeutics Inc Transaction History
Prudential Financial Inc
- $80 Billion
- Q3 2025
A detailed history of Prudential Financial Inc transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Prudential Financial Inc holds 25,840 shares of PRLD stock, worth $39,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,840Holding current value
$39,535% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRLD
# of Institutions
48Shares Held
27.5MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$16.7 Million0.5% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$15.5 Million0.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.15MShares$1.75 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.07MShares$1.64 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA993KShares$1.52 Million0.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $55.6M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...